Amphastar Pharmaceuticals, Inc. (AMPH)

Price$18.42

Value ScoreA

Growth ScoreC

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-41.60%

Price vs S&P 500 (4W)-18.82%

VGM Score56.22

Market Capitalization$831.15M

P/E Ratio (Annual)8.47x

All Metrics

P/CF (Annual)5.32x

Book Value / Share (Quarterly)$17.33

P/TBV (Annual)5.44x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)12.99%

Cash Flow / Share (Quarterly)$2.98

Price vs S&P 500 (YTD)-40.55%

Gross Margin (TTM)47.34%

Net Profit Margin (TTM)11.00%

EPS (TTM)$1.67

10-Day Avg Trading Volume0.79M

EPS Excl Extra (TTM)$1.67

Revenue Growth (5Y)15.53%

EPS (Annual)$2.03

ROI (Annual)7.01%

Gross Margin (Annual)49.46%

Net Profit Margin (5Y Avg)17.85%

Cash / Share (Quarterly)$6.54

P/E Basic Excl Extra (TTM)10.49x

Revenue Growth QoQ (YoY)0.38%

EPS Growth (5Y)134.81%

P/E Normalized (Annual)8.47x

ROA (Last FY)6.02%

Revenue Growth TTM (YoY)-1.39%

EBITD / Share (TTM)$2.80

ROE (5Y Avg)17.39%

Operating Margin (TTM)16.20%

Cash Flow / Share (Annual)$2.61

P/B Ratio1.07x

P/B Ratio (Quarterly)1.15x

Net Income / Employee (Annual)$49,600

EV / Revenue (TTM)1.76x

Net Interest Coverage (TTM)8.36x

ROA (TTM)4.83%

EPS Growth QoQ (YoY)-72.04%

EV / EBITDA (TTM)9.63x

EPS Incl Extra (Annual)$2.03

Current Ratio (Annual)4.02x

Quick Ratio (Quarterly)2.75x

3-Month Avg Trading Volume0.56M

52-Week Price Return-26.48%

EV / Free Cash Flow (Annual)10.69x

P/E Incl Extra (TTM)10.49x

Revenue / Employee (TTM)$364,600

Tangible BV / Share (Quarterly)$4.86

P/S Ratio (Annual)1.15x

Asset Turnover (Annual)0.44x

52-Week High$31.26

Operating Margin (5Y Avg)23.44%

EPS Excl Extra (Annual)$2.03

CapEx CAGR (5Y)1.86%

Tangible BV CAGR (5Y)-9.15%

26-Week Price Return-25.67%

Quick Ratio (Annual)2.82x

13-Week Price Return-28.84%

Total Debt / Equity (Annual)0.77x

Current Ratio (Quarterly)3.85x

Enterprise Value$1.27B

Revenue / Share Growth (5Y)15.95%

Asset Turnover (TTM)0.44x

Book Value / Share Growth (5Y)15.33%

Revenue / Employee (Annual)$364,300

Inventory Turnover (Annual)2.20x

Pretax Margin (Annual)17.17%

Cash / Share (Annual)$6.20

3-Month Return Std Dev76.34%

Gross Margin (5Y Avg)50.19%

Net Income / Employee (TTM)$40,100

EBITDA CAGR (5Y)49.01%

EBITDA Interim CAGR (5Y)14.69%

ROE (Last FY)12.44%

Net Interest Coverage (Annual)7.14x

EPS Basic Excl Extra (Annual)$2.03

P/FCF (TTM)6.25x

Receivables Turnover (TTM)4.93x

EV / Free Cash Flow (TTM)9.57x

Total Debt / Equity (Quarterly)0.79x

EPS Incl Extra (TTM)$1.67

Receivables Turnover (Annual)5.14x

ROI (TTM)5.72%

P/S Ratio (TTM)1.15x

Pretax Margin (5Y Avg)22.43%

Revenue / Share (Annual)$14.93

Tangible BV / Share (Annual)$4.96

Forward P/E6.38x

Free OCF CAGR (5Y)38.43%

Price vs S&P 500 (52W)-54.69%

P/E Ratio (TTM)10.49x

EPS Growth TTM (YoY)-39.45%

Year-to-Date Return-29.61%

5-Day Price Return2.39%

EPS Normalized (Annual)$2.03

ROA (5Y Avg)9.36%

Net Profit Margin (Annual)13.63%

Month-to-Date Return-14.16%

Cash Flow / Share (TTM)$3.20

EBITD / Share (Annual)$3.21

EPS Growth (3Y)5.26%

Operating Margin (Annual)19.50%

LT Debt / Equity (Annual)0.77x

P/CF (TTM)4.92x

ROI (5Y Avg)11.43%

P/E Excl Extra (TTM)10.49x

LT Debt / Equity (Quarterly)0.79x

EPS Basic Excl Extra (TTM)$1.67

P/TBV (Quarterly)4.09x

P/B Ratio (Annual)1.56x

Inventory Turnover (TTM)2.13x

Pretax Margin (TTM)14.27%

Book Value / Share (Annual)$17.28

Price vs S&P 500 (13W)-38.59%

Net Margin Growth (5Y)102.53%

Beta0.91x

P/FCF (Annual)6.99x

Revenue / Share (TTM)$15.90

ROE (TTM)10.23%

52-Week Low$16.65

vGradeA

gGradeC

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.42est. 0.72

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.92

3.85

3.69

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
AMPHAmphastar Pharmaceuticals, Inc.	A	C	D	$18.42
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
ABTAbbott Laboratories	C	C	D	$87.78
PFEPfizer Inc.	B	C	C	$25.63
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Amphastar Pharmaceuticals manufactures generic and proprietary injectable, inhalation, intranasal, and insulin products for hospitals and urgent care settings. Its products are distributed through group purchasing organizations and drug wholesalers, with operations primarily in the United States and supplemented by facilities in China and France.